Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): A family-based approach

Molecular Psychiatry

Volumn 3, Issue 1, 1998, Pages 38-41

  Swanson, J M ^a   Sunohara, G A ^b   Kennedy, J L ^b   Regino, R ^a   Fineberg, E ^a   Wigal, T ^a   Lerner, M ^a   Williams, L ^a   LaHoste, G J ^a   Wigal, S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Attention deficit hyperactivity disorder; Dopamine; DRD4; Genetics

Indexed keywords

DOPAMINE 4 RECEPTOR;

ARTICLE; ATTENTION DEFICIT DISORDER; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POPULATION GENETICS; PRIORITY JOURNAL; RECEPTOR GENE;

EID: 15144354766     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000354     Document Type: Article

References (36)

1. LaHoste GJ, Swanson JM, Wigal SB, Glabe C, Wigal T, King N et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1996; 1: 121-124.
2. Petronis A, Van Tol HH, Lichter JB, Livak KJ, Kennedy JL. The D4 dopamine receptor gene maps on 11p proximal to HRAS. Genomics 1993; 18: 161-163.
3. Van Tol HHM, Wu CM, Guan HC, Ohara K, Bunzow JR, Civelli O et al. Multiple D4 receptor variants in the human population. Nature 1992; 358: 149-152.
4. Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HH. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J Neurochem 1995; 65: 1157-1165.
5. Ebstein RP, Novick O, Umansky R, Priel B, Osher Y, Blaine D et al. Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty Seeking. Nature Genet 1996; 12: 78-80.
6. Benjamin J, Li L, Patterson C, Greenberg BD, Murphy DL, Hamer DH. Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nature Genet 1996; 12: 81-84.
7. Cloninger CR, Adolfsson R, Svrakic NM. Mapping genes for human personality. Nature Genet 1996; 12: 3-4.
8. Seeman P. Dopamine receptors and psychosis. Science & Medicine 1995; 2: 28-37.
9. Sunohara GA, Kennedy JL. The dopamine D4 receptor gene and neuropsychiatric disorders. Dopaminergic Disorders. IBC Press (in press).
10. Petronis A, Macciardi F, Athanassiades A, Paterson AD, Massimiliano V, Meltzer HY et al. Association study between the dopamine D4 receptor gene and schizophrenia. Am J Med Genet 1994; 60: 452-455.
11. Chang FM, Kidd JR, Livak KJ, Pakstis AJ, Kidd KK. The worldwide distribution of allele frequencies at the human dopamine D4 receptor locus. Human Genet 1996; 98: 91-101.
12. Ewens WJ, Spielman RS. The transmission/disequilibrium test: history, subdivision, and admixture. Am J Hum Genet 1995; 57: 455-464.
13. Thomson G. Mapping disease genes: family-based association studies. Am J Hum Genet 1995; 57: 487-498.
14. Spielman RS, Ewens WJ. Invited Editorial: The TDT and other family-based tests for linkage disequilibrium and association. Am J Hum Genet 1996; 59: 983-989.
15. Falk CT, Rubinstein P. Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations. Ann Hum Genet 1987; 51: 227-233.
16. Sham PC, Curtis D. An extended transmission/disequilibrium test (TDT) for multi-allele marker loci. Ann Hum Genet 1995; 59: 323-336.
17. Swanson J. Hyperkinetic disorders and attention-deficit hyperactivity disorders. Curr Opin Psychiatry 1997; 10: 1-5.
18. Swanson J, Posner M, Cantwell D, Wigal S, Crinella F, Filipek P et al. Attention-deficit/hyperactivity disorder: symptom domains, cognitive processes and neural networks. In: Parasuraman R (ed), The Attentive Brain. MIT Press: Boston, (in press).
19. Sunohara GA, Swanson JM, LaHoste G, Wigal S, King N, Sam F et al. Association of dopamine receptor genes in attention deficit hyperactivity disorder. Am J Hum Genet 1996; 59S: A1370.
20. Cook EH, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Keiffer JE et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995; 56: 993-998.
21. Gill M, Daly G, Heron S, Hawi Z, Fitzgerald M. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Mol Psychiatry 1997; 2: 311-313.
22. Comings DE, Wu S, Chiu C, Ring RH, Gade R, Ahn C et al. Polygenic inheritance of Tourette syndrome, stuttering, attention deficit hyperactivity, conduct, and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes - DRD2, D beta H, and DAT1. Am J Med Genet 1996; 67: 264-288.
23. Lander E, Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nature Genet 1996; 11: 241-247.
24. Deutsch CK, Matthysse S, Swanson JM, Farkas LG. Genetic latent structure analysis of dysmorphology in attention deficit disorder. J Am Acad Adolescent Psychiatry 1990; 29: 189-194.
25. Farone SV, Biederman J, Chen WJ, Krifcher B, Keenan K, Moore C et al. Segregation analysis of attention deficit hyperactivity disorder. Psychiatric Genet 1992; 2: 257-275.
26. Shaywitz BA, Yager RD, Klopper JH. Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction. Science 1976; 191: 305-330.
27. Lou HC. Etiology and pathogenesis of attention-deficit hyperactivity disorder (ADHD): significance of prematurity and perinatal hypoxic-haemodynamic encephalopathy. Acta Paediatrica 1996; 85: 1266-1271.
28. Castellanos FX. Toward a pathophysiology of attention-deficit/hyperactivity disorder. Clin Pediatrics 1997; 36: 381-393.
29. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders (4th edition), Washington, DC, 1994.
30. The ICD-10 Classification of Mental and Behavioral Disorders: Clinical descriptions and diagnostic guidelines. World Health Organization: Geneva, 1993.
31. Swanson JM, Sergeant J, Taylor E, Sonuga-Barke E, Jensen P, Cantwell D. Attention deficit hyperactivity disorder and hyperkinetic disorder. The Lancet (submitted).
32. Filipek PA, Semrud-Clikeman M, Steingard RJ, Renshaw PF, Kennedy DN, Biederman J. Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls. Neurology 1997; 48: 589-601.
33. Posner MI, Raichle ME. Images of Mind. Scientific American Library: New York, 1994.
34. Shaffer D, Fisher P, Dulcan MK, Davies M, Piacentini J, Schwab-Stone ME et al. The NIMH Diagnostic Interview Schedule for Child Version 2.3 (DISK-2.3). Description, Acceptability, Prevalence Rates, and Performance in the Meca Study. J Am Acad Child Adolescent Psychiatry 1993; 35: 865-877.
35. Swanson J. School-based assessments and interventions for ADD students. Irvine: KC Publishing: Irvine, 1992.
36. Lichter JB, Barr CL, Kennedy JL, Van Tol HH, Kidd KK, Livak KJ. A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Hum Mol Genet 1993; 2: 767-773.